Dr Amina Jindani is an Honorary Senior Lecturer at St George’s, University of London where she is coordinating the International Consortium for Trials of Chemotherapeutic Agents in Tuberculosis, known as INTERTB.
An international trial, conducted by Dr Jindani, has led to changes in the recommendations by the World Health Organisation (WHO) for the treatment of tuberculosis.
In June 2003, Dr Jindani was elected as a Fellow of the Royal College of Physicians of London.
Her postdoctoral thesis was based on the early bactericidal activity of tuberculosis drugs on the rate of reduction of the bacterial load in the sputum. This method is now applied in the evaluation of new drugs for tuberculosis.
She has been involved with clinical trials of tuberculosis since the 1960s when she coordinated the first East African/British Medical Research Council trial of short-course chemotherapy in Africa.
She was awarded a Bachelor’s degree from the University of London, accompanied by special awards in Paediatrics and Pharmacology and membership of the Royal College of Physicians of the United Kingdom.
Jindani, A. 1979.The effect of single and multiple drugs on the viable count of M. tuberculosis in the sputum of patients with pulmonary tuberculosis during the early days of treatment. Thesis for the degree of Doctor of Medicine, London University.
Jindani, A., V.R. Aber, E.A. Edwards and D.A. Mitchison. 1980. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am. Rev. Resp. Dis. 121: 939-949.
Harries, A.D, Hargreaves, N.J, Kemp, J, Jindani, A, Enarson, D.A, Maher, D, and Salaniponi, F. M. 2001. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet. 357: 1519-1523.
Amina Jindani, Caroline J Dore, and Denis A Mitchison. 2003. The bactericidal and sterilising activities of antituberculosis drugs during the first 14 days Am. J. Respir. Crit. Care Med 2003. 167:1348-1354.
Jindani A, Nunn AJ, Enarson DE. 2004.Two eight-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet. 2004. 364 : 1244-1251.
Jindani A, Griffin GE. 2010 . Challenges to the development of new drugs and regimens for tuberculosis. Tuberculosis (Edinb). May;90(3):168-70. Epub 2010 Apr 10.
Dr Jindani works with David Coleman, a senior microbiology technologist.
Dr Mark Hatherill, Satvi, Institute of Infectious Disease & Molecular Medicine, University of Cape Town, South Africa
Dr Salome Charalambous, Aurum Institute for Health Research, Johannesburg, South Africa
Dr Stanley Mungofa, Harare City Health Department, Harare City, Harare, Zimbabwe
Dr Simukai T Zizhou, Provincial Medical Directorate Mashonaland East, Marondera, Zimbabwe
Dr Janneke van Dijk, Macha Zambia Medical/Malaria Institute at Macha, Macha Mission Hospital, Choma, Zambia
Dr James Shepherd, BOTUSA, Gaborone, Botswana
Dr Bhabhana Shrestha, GENETUP, Kalimati, Kathmandu, Nepal
Mrs Ilona Westermann de Patiño, Centers Broncopulmonares, Santa Cruz, Bolivia
Dr Daniel Atwine, MSF- Epicentre, Mbarara, Uganda